Menu

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6006528)

5 Amino salicylic acid 400 mg Tab,Abiraterone Acetate 500 mg Tab,Acalabrutinib 100 mg cap,Acarbose

Goods
Qty:29.6L
EMD: ₹3,492
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6006528)

Tender Timeline

Tender Issue
April 25, 2025 at 2:43 PM

Tender Title: CDL ITEMS

Reference Number: GEM/2025/B/6006528

Issuing Authority/Department

This tender is issued by the Department of Military Affairs under the Ministry of Defence.

Scope of Work and Objectives

The primary objective of this tender is to procure 5 Amino Salicylic Acid 400 mg Tabs, along with other specified pharmaceutical items such as Abiraterone Acetate 500 mg Tabs, Acalabrutinib 100 mg Caps, and Acarbose. The total quantity of items required is 2,961,492 units. Suppliers are expected to ensure timely delivery and compliance with all specified technical and quality standards.

Eligibility Criteria

To be eligible for participation in this tender, bidders must meet specific requirements, including being a registered entity in India with prior experience in supplying similar pharmaceutical products. Bidders must also demonstrate the ability to meet quantity demands and adhere to delivery schedules. Familiarity with relevant pharmaceutical regulations and quality standards is essential.

Technical Requirements

All products must comply with the applicable specifications and quality standards set forth by the Ministry of Defence. Detailed technical specifications for each item are part of the bidding documents and must be strictly adhered to. Bidders are expected to provide verifiable documentation supporting technical compliance.

Financial Requirements

Bidders must submit a Financial Bid that details pricing for the items listed in the tender, ensuring that it aligns with market rates and the quality expectations of the Department of Military Affairs. Compliance with pricing regulations and transparency in financial dealings is mandatory.

Document Submission Details

Bidders are required to submit their bids electronically via the designated government portal. The submission must include all necessary documents, including technical specifications, financial proposals, and any other required certifications. It is advisable to check the portal for any specific document formatting requirements.

Special Provisions

In consideration of inclusivity, special provisions may be available for Micro, Small, and Medium Enterprises (MSEs) and Startups. Bidders falling under these categories may enjoy certain benefits such as relaxations in eligibility criteria or reduced submission fees, if applicable.

Evaluation Process

Proposals will undergo a thorough evaluation process based on technical compliance, financial feasibility, and the overall value offered. The evaluation will prioritize adherence to specifications, quality assurance, and cost-effectiveness. Bidders must present transparent and corroborative details in their offers.

Delivery Locations

Successful bidders will be required to deliver the specified pharmaceutical items to locations as directed by the Department of Military Affairs. Detailed logistical arrangements and timelines should be discussed during the bid submission process, as delivery efficiency is a critical aspect of this tender.

Contact Information

For further inquiries regarding the tender, bidders are encouraged to contact the Department of Military Affairs directly through the official government communication channels available on the tender portal.

This document aims to provide all essential information for interested bidders, facilitating a clear understanding of the requirements and processes involved in responding to this tender.


General Information

Ministry Name
Organisation Name
State

Financial Information

EMD Amount
₹3,492.00
OEM Average Turnover
₹59.00 Lakh (s)
Minimum Turnover
₹59.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
50 %
Arbitration Clause
Yes (Arbitration clause document) as per DoE OM No.F.1/2/2024-PPD dated 03.06.2024 Arbitration should not be routinely included in contracts
Mediation Clause
Yes (Mediation clause document) as per DoE OM No.F.1/2/2024-PPD dated 03.06.2024 mediation clause should not be routinely included in contracts and pre- litigation mediation can be taken up without any such clause also

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

7 Documents
GeM-Bidding-7586740.pdfMain Document
Other DocumentsOTHER
Other DocumentsOTHER
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Antacid Tab,Acetazolamide,Acetyl Salicylic Acid Tab,Albendazole,Alprazolam,Amitriptyline HCL,Amlodi

GEM
Goods
Qty:4Cr
6 Files
N/a
CENTRAL DELHI, DELHI
Boq › Boql
Antacid Tab , Acetazolamide , Acetyl Salicylic Acid Tab , Albendazole , Alprazolam , Amitriptyline HCL , Amlodipine , Amoxycillin Trihydrate , Ascorbic Acid , Atenolol , Atorvastatin , Azithromycin , B Complex Vitamin , Bisacodyl tablet , Bromhexine , Betahistine Hcl , Calcium citrate carbonate , Carbamazepine , Carvedelol , Cetrizine , Charcoal , Chloroquine Phosphate , Ciprofloxacin Hydrochloride , Clonidine Hydrochloride , Clopidogrel , Cefixime , Domperidon , Dexamethasone , Diclofenac Sodium , Digoxin , Diltiazem Hydrochloride , Dothiepin Hydrochloride , Doxycycline Hydrochloride , Drotaverine , Enalapril Maleate , Erythromycin Stearate , Ferrous Salt , Fluconazole , Fluoxetine HCL Capsule , Folic acid , Glibenclamide , Glimepiride , Haloperidol , Hydroxychloroquine , Hyoscine Butyl Bromide , Imipramine HCL , Isosorbide Dinitrate , Isosorbide Mononitrate , Itraconazole , Lorazepam , Lithium carbonate , Levetiracetam , Metformin , Metronidazole , Metoclopramide Hcl , Metoprolol , Multivitamins , Norfloxacin , Olanzepine , Pantoprazole , Paracetamol , Pheniramine Maleate , Phenobarbitone , Phenytoin Sodium , Prednisolone , Pregabalin , Rosuvastatin , Propranolol Hcl , Ranitidine Hcl , Resperidone , Salbutamol , Sodium Valproate , Spironolactone , Sertaline , Theophyllin , Thyroxin Sodium , Trifluoperazine Hcl , Trihexiphenidyl , Trimethoprim , Torsamide , Thiamine
April 22, 2025
May 22, 2025 at 12:00 PM
View Details

Ivermectin 12 mg Tab,Corn Cap 40 percent Sallicylic Acid,Miconazole Nitrate 2 percent Ung 15 gm,Cap

GEM
Goods
Qty:29.3K
4 Files
Indian Army
AMBALA, HARYANA
Boq › Boql
Ivermectin 12 mg Tab , Corn Cap 40 percent Sallicylic Acid , Miconazole Nitrate 2 percent Ung 15 gm , Cap Minocycline ER 65 mg , Hydrous Benzoyl Peroxide IP FACE WASH 4 percent of 50 , Clindamycin 1 percent w v Benzoyl peroxide 5 percent w w , Clindamycin 1 percent plus Nicotinamide 4 percent 20 gm tube , Clobetasol Propionate 0 point 05 percent plus Buffered lactic acid , Cyclophosphamide 500 mg Inj , Gel Luliconazole 1 percent with Sepineo and Biochitoderm , Halobetasol proprionate 0 point 05 percent cream 50 gm , Hydrocortisone Acetate Cream 1 percent Tube of 15 gm , Inj Bleomycin Sulphate 15 Units , inj Triamcinolone Acetate 10Mg ml , Lot Clotrimazole 1 percent plus Beclomethasone 0 point 0 , Lot Minoxidil 10 percent Bott of 60ml , 50 precent Glycolic acid Peel 60ml with Pre Peel liposomal , Aloevera 10 point 0 percent Vitamin E 0 point 5 percent , Azelaic Acid 20percent Cream Tube of 15 gm , Mometasone Lotion 0 point 1 percent Tube of 15ml , PRP kit , Tab Minoxidil 2 point 5 mg , Tacrolimus ointment 0 point 03 percent Tube of 20 gram , Tretinoin gel 0 point 025 percent tube of 20 gram , Yellow Peel Kit 10 percent Ascorbyl Glucoside and 5 percent , Zinc Oxide and Benzalkonium chloride cream tube of 30 gram , 0 point 1 percent Triamcinolone Acetonide Bucccal Parts , White Soft Paraffin ,Light Liquid Paraffin,Light Liquid Paraffin , Ivermectin 6mg Tab , Luliconazole 1 percent Cream 30gm , Minoxidil 2 percent Lotion 60 ml , Methotrexate LP Liposomal topical gel 1 percent Tube , Minoxidil 5 percent wv plus Finasteride 0 point 1 , Bilastine 10 mg Tab , Ketoconazole 2 percent and Salicyclic acid 2 percent , Tab Fluconazole 400 mg Tab , Ciclopiroxolamine 1 percent Cream 30gm , Deca Peptide Solution of 2 ml , Triamcinolone Acetonide 40mg Inj , Lot lacquer nail amorlfine 5 percent 2 point 5ml , Disposable skin biopsy punches size 5 mm , Disposable skin biopsy punches size 6 mm , 0 point 4 percent Tretinoin Microsphere gel Tube of 20 gm , Ciclopirox 1 percent Zinc Pyrithidone 1 percent , Clotrimazole 1 percent plus Selenium Sulphate 2 point 5 percent , Lactic Acid 17 percent Salicylic Acid 17 percent isopropyl alcohol , Amorolfine 0 point 25percent Ung 20 gm , Imiquimod 5percent Ung , Adapalene 0 point 1 percent Tube of 15 gm , Tacrolimus Oint 0 point 1 percent 20 gm tube , Benzoyl Peroxide 2 point 5 percent Tube of 20 gm , Lot Octinoxate 7 point 5 percent plus Oxybenzone 3 percent plus , Disposable Miniature Punches Size 3 mm , Disposable miniature punches size 4 mm , Ung Kojic acid 3percent vit c 15gm , Clindamycin phosphate 1 percent topical gel Tube of 10 gm , Fluticasone 0 point 05percent oint Tube of 10 gm , Permethrin 5 percent Tube of 30 gm , Podophyllin Resin 20 percent bott of 10 ml , Halobetasol proprionate lotion 0 point 05 percent , Eberconazole Ung 30 gm , Fluocinolone acetonide 0 point 01 percent Hydroquinone , Valacyclovir 1gm Tab , Tofacitinib 2 percent cream tube of 30 gm
April 25, 2025
May 16, 2025 at 11:00 AM
View Details

Succinylchloline Chloride 50 mg per ml, 2 ml Inj,Cap Tacrolimus 0.25 mg,Flavoxate 200mg Tab,Erythro

GEM
Goods
Qty:47.3K
4 Files
Indian Navy
UTTARA KANNADA, KARNATAKA
Boq › Boql
Succinylchloline Chloride 50 mg per ml, 2 ml Inj , Cap Tacrolimus 0.25 mg , Flavoxate 200mg Tab , Erythropoeitin Human Recombinant 4000 IU , Papaverine Hydrochloride 50 mg, 2 ml Inj , Sevelamer Carbonate Sachet 800mg , Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen , Gentamicin sulphate 0.3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml , Brimonidine Tartrate 0.2 percent, Eye drops , Clobazam 5 mg Tab , Lorazepam 2 mg per ml, 2 ml Inj , Gabapentin 300 mg Cap or Tab , Sodium Valproate 100 mg per ml Inj , Lamotrigine 25 mg Tab , Sumatriptan 50 mg Tab , Topiramate 25 mg Tab , Nimodipine 30 mg Tab , Canagliflozin 100mg tab , Carbimazole 20 mg Tab , Tab Tenofovir 300mg , Tab Entacavir 0.5mg , Omeprazole 20 mg Cap , Pantoprazole 40mg Inj , Ranitidine HCl 50 mg, 2 ml Inj , Metoclopramide syrup 5mg per 5ml bott of 30ml , Hydrocortisone Enema 10 percentage , Dicyclomine HCl 20 mg Inj , Tab or Cap Dicyclomine 10mg , Bisacodyl 5 mg Tab , Sodium phosphate solution 45 ml, each Pack of 2 bottle , Tab Dapagliflozin 10mg , Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m... , Baclofen XL 30 mg Tab , Clozapine 50 mg Tab , Ranolazine 500 mg Tab , Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0.03 mg, Norgestrel 0.30 mg Tab
April 25, 2025
May 16, 2025 at 10:00 AM
View Details

Frequently Asked Questions

The eligibility requirements for this tender include being a registered entity in India, possessing prior experience in supplying pharmaceutical products, and demonstrating the capacity to meet the extensive quantity demands outlined. Bidders must also comply with specific regulations and should have a sound understanding of relevant quality standards.

Bidders are required to meet the technical specifications outlined for each pharmaceutical item in the tender documentation. Products must adhere to applicable quality standards defined by the Ministry of Defence, ensuring that they are safe, effective, and suitable for intended use. Compliance with pharmaceutical regulations is essential, and bidders must provide documentation to confirm this compliance.

The Earnest Money Deposit (EMD) details specific to this tender must be confirmed through the tender document submission guidelines. Generally, EMD is required to ensure commitment from bidders towards their proposals and will be forfeited if a bidder withdraws post-bid submission. Payment terms will also highlight any financial guarantees expected throughout the tendering process.

Bids must be submitted electronically through the designated government portal, following specified submission guidelines. Key timelines and deadlines for submission will be available on the portal; therefore, prospective bidders should regularly review these timelines to ensure timely participation in the evaluation and selection process.

Yes, this tender includes provisions to support Micro, Small, and Medium Enterprises (MSEs) and potentially Startups. Eligible bidders may receive advantages such as relaxed qualification criteria or reduced costs associated with participation. MSEs are encouraged to take advantage of such provisions to foster a competitive and inclusive bidding environment.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders